NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 24th Apr 2025 NOVO-B SHARE Price closed @ 410.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 845.84 & Strong Sell for SHORT-TERM with Stoploss of 699.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSHARE Price

Open 400.70 Change Price %
High 412.40 1 Day 1.20 0.29
Low 398.45 1 Week 0.55 0.13
Close 410.10 1 Month -139.30 -25.35
Volume 4900365 1 Year -291.00 -41.51
52 Week High 1028.00 | 52 Week Low 390.00
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 410.10 0.29%
CONFRZ 0.02 0.00%
TGAMES 7.34 6.69%
VWS 86.06 -1.98%
GREENH 0.27 -3.57%
ALMB 15.42 1.58%
BIF 0.39 0.00%
ASTRLS 1.15 8.49%
DANSKE 218.00 -1.54%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
NEXCOM 4.28 24.42%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
ATLA-DKK 2.74 10.04%
GYLD-B 339.70 9.58%
ASTRLS 1.15 8.49%
STRINV 0.91 7.06%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
MONSO 0.26 -13.33%
HAPPY 0.18 -10.00%
DAC 6.50 -9.09%
DAC 6.50 -9.09%
DAC 6.50 -9.09%
SCAPE 0.11 -8.33%
GJ 62.01 -8.13%
SIG 3.15 -5.12%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE436.98
RESISTANCE428.36
RESISTANCE423.03
RESISTANCE417.70
SUPPORT402.50
SUPPORT397.17
SUPPORT391.84
SUPPORT383.22
 
NOVO-B Forecast April 2025
4th UP Forecast600.68
3rd UP Forecast539.56
2nd UP Forecast501.78
1st UP Forecast464
1st DOWN Forecast356.2
2nd DOWN Forecast318.42
3rd DOWN Forecast280.64
4th DOWN Forecast219.52
 
NOVO-B Weekly Forecast
4th UP Forecast512.23
3rd UP Forecast479.48
2nd UP Forecast459.23
1st UP Forecast438.99
1st DOWN Forecast381.22
2nd DOWN Forecast360.97
3rd DOWN Forecast340.72
4th DOWN Forecast307.97
 
NOVO-B Forecast2025
4th UP Forecast1668.82
3rd UP Forecast1265.14
2nd UP Forecast1015.62
1st UP Forecast766.09
1st DOWN Forecast54.11
2nd DOWN Forecast-195.42
3rd DOWN Forecast-444.94
4th DOWN Forecast-848.62
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service